Background illustration for clinical trials search

Paid Clinical Trials Nebraska

Discover 626 paid clinical trials in Nebraska. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

for
Amblyopia
Location: Beverly MA, Boston MA, New Haven CT, New York NY,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 4 - 7

Code: NCT06380517

Phase3, Recruiting

EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

for
Kidney Disease, Chronic
Location: Halifax, Portsmouth NH, East Providence RI, Quebec,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06531824

Phase3, Recruiting

A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)

for
Multiple Myeloma
Location: Fredericton, Boston MA, Newton MA, Worcester MA,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06215118

Phase1, Recruiting

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

for
Asthma
Location: South Dartmouth MA, Boston MA, Jersey City NJ,
Sponsor: Teva Branded Pharmaceutical Products R&D LLC

Sex: All

Age: 12+

Code: NCT06664619

Phase3, Recruiting

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

for
DLBCL, Diffuse Large B-Cell Lymphoma
Location: Valhalla NY, Horsham PA, Boca Raton FL, Hialeah FL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05139017

Phase2, Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

for
mCRPC (Metastatic Castration-resistant Prostate Cancer),
Location: New York NY, Baltimore MD, Fairfax VA, Durham NC,
Sponsor: Pathos AI, Inc.

Sex: Male

Age: 18+

Code: NCT06785636

Phase1, Phase2, Recruiting

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Boston MA, New York NY, Hackensack NJ, Buffalo NY,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06121843

Phase1, Recruiting

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

for
Metastatic Castration-Resistant Prostate Cancer
Location: Halifax, Chicoutimi, The Bronx NY, Montreal,
Sponsor: Pfizer

Sex: Male

Age: 18+

Code: NCT06629779

Phase3, Recruiting

Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

for
Prostate Cancer,
Location: Miami FL, Atlanta GA, Omaha NE
Sponsor: Blue Earth Therapeutics Ltd

Sex: Male

Age: 18+

Code: NCT05413850

Phase1, Phase2, Recruiting

Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Photorefractive Keratectomy (PRK)

for
Dry Eye
Location: Omaha NE
Sponsor: Brandon Baartman

Sex: All

Age: 18+

Code: NCT05045508

Phase3, Recruiting

Chest Drain Regular Flushing in Complicated Parapneumonic Effusions and Empyemas

for
Empyema, Pleural, Pleural Infection
Location: New York NY, Richmond VA, Sterling Heights MI,
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 18+

Code: NCT06427538

Recruiting

Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)

for
Acute Respiratory Distress Syndrome, Infections
Location: Montreal, Hershey PA, Toronto, Pittsburgh PA,
Sponsor: BioAegis Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT05947955

Phase2, Recruiting

Oxygen-guided Supervised Exercise Therapy

for
Peripheral Artery Disease
Location: Omaha NE
Sponsor: VA Office of Research and Development

Sex: All

Age: 0+

Code: NCT06003855

Recruiting

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer
Location: Boston MA, New Haven CT, Montreal, Baltimore MD,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05061550

Phase2, Recruiting

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

for
Relapsed Diffuse Large B-cell Lymphoma,
Location: West Reading PA, Greenville NC, Pittsburgh PA,
Sponsor: ImmunoVaccine Technologies, Inc. (IMV Inc.)

Sex: All

Age: 18+

Code: NCT04920617

Phase2, Recruiting

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

for
NSCLC, Stage I
Location: New Brunswick NJ, Hershey PA, Richmond VA,
Sponsor: Greg Durm, MD

Sex: All

Age: 18+

Code: NCT04317534

Phase2, Recruiting

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

for
Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma,
Location: The Bronx NY, New York NY, Hackensack NJ,
Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT05826535

Phase1, Phase2, Recruiting

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Boston MA, Lake Success NY, The Bronx NY, Brooklyn NY,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06479135

Phase3, Recruiting

Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease

for
Peripheral Artery Disease, Peripheral Vascular Diseases,
Location: Omaha NE
Sponsor: University of Nebraska

Sex: All

Age: 50 - 70+

Code: NCT06319339

Early_phase1, Recruiting

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

for
AL Amyloidosis
Location: Boston MA, Guilford CT, Hartford CT, North Haven CT,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06022939

Phase3, Recruiting

Popular cities in Nebraska

LincolnBellevueOmaha